KAYLEEN LYNCH: Open Payments
NPI 1417547886 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,963 in 58 payments from 14 companies in 2025. Trend: 2023 $206 · 2024 $952 · 2025 $1,963
Food & beverage: $1,963
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $519 |
| Eisai Inc. | 17 | $361 |
| MDD US Operations, LLC | 2 | $176 |
| UCB, Inc. | 3 | $134 |
| AstraZeneca Pharmaceuticals LP | 1 | $126 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| Biogen, Inc. | 4 | $118 |
| Lilly USA, LLC | 5 | $104 |
| E.R. Squibb & Sons, L.L.C. | 1 | $87 |
| ARGENX US, INC. | 3 | $77 |
Products named: Leqembi, QULIPTA, Gocovri, UBRELVY, ZEPOSIA, REXULTI, AMYVID, VYVGART HYTRULO.
Industry payments across VA — which companies pay providers there.
